Genmab — April 2018

[AaBforever]

Det går stærkt nu...:-(

[AaBforever]

Godt at jeg kom ud af bullx4..:-)

[polle1]

jkj : din forudsigelse var ikke helt "præcis" idag

[E_L]

European markets trading roughly at the level of Wednesday 17.00 when copenhagen closed, so seems a bit of an overreaction here for Genmab

[Mayflower]

@polle1 Biotech har vel heller aldrig rigtigt kunnet karakteriseres som sikker havn!

[Mayflower]

Jeg glæder mig over laksen svømmer mod strømmen!

[concillado]

GEN is always the target of overreactions.. nothing suprises me anymore in this matter

[OHW]

Vi skal måske lige ned og teste 1240 niveau.

[E_L]

or up and test 1300

[E_L]

did we post this yet:

[E_L]

New: Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT03485209?term=daratumumab+OR+ofatumumab+OR+tisotumab&lupd_s=03%2F29%2F2018&rank=3

[Legolas23]

Måske short-attack oven på Trump-farcen

[polle1]

@mayflower : nej, netop !

[jkj]

Tror lige krystalkuglen,, skal pudses med til AJAX

[hda]

Endnu en god opkøbsmulighed. Elsker dem

[E_L]

Ofatumumab Safe, Effective for B Cell Depletion in Rituximab-Intolerant SLE,
Rheumatology Advisor, http://www.rheumatologyadvisor.com/systemic-lupus-erythematosus/ofatumumab-effective-for-b-cell-depletion-in-systemic-lupus-erythematosus/article/755223/

[Bulder]

Yes why not. Ofa is effective in autoimmune deseases. GSK already saw this, when they tested ofa in RA. An indication that Novartis hasn't resumed yet.

[Bulder]

... diseases

[AaBforever]

Hvor ender vi i dag?

[AaBforever]

Købte nogle bulls i morges som jeg skal have fyret af.